Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-17
Closed -$2.25K – 4463
2017
Q3
$2K Buy
+17
New +$2.27K ﹤0.01% 4284
2017
Q1
– Sell
-2,343
Closed -$277K – 4668
2016
Q4
$258K Buy
+2,343
New +$260K ﹤0.01% 3125
2016
Q3
– Sell
-1,541
Closed -$182K – 4494
2016
Q2
$172K Sell
1,541
-12,857
-89% -$1.38M ﹤0.01% 3253
2016
Q1
$1.45M Buy
+14,398
New +$1.38M 0.01% 1385
2015
Q4
– Sell
-4,408
Closed -$455K – 5042
2015
Q3
$411K Buy
+4,408
New +$456K ﹤0.01% 3065
2015
Q2
– Sell
-7,659
Closed -$797K – 5268
2015
Q1
$830K Sell
7,659
-18,269
-70% -$1.88M 0.01% 2074
2014
Q4
$2.4M Buy
25,928
+23,338
+901% +$2.06M 0.02% 1157
2014
Q3
$226K Buy
2,590
+396
+18% +$35.8K ﹤0.01% 3208
2014
Q2
$193K Sell
2,194
-309
-12% -$26.8K ﹤0.01% 3250
2014
Q1
$211K Buy
+2,503
New +$200K ﹤0.01% 3385
2013
Q3
– Sell
-8,846
Closed -$761K – 5309
2013
Q2
$761K Buy
+8,846
New +$734K ﹤0.01% 2384

Other funds holding LH

PEAK6 Group's LH Position: Q4 2017 in Review

PEAK6 Group sold out of Labcorp (LH) in Q4 2017, closing a stake of 17 shares — an estimated $2.25K sold.

PEAK6 Group first reported a position in LH in Q2 2013 and held it in 11 quarters. The position peaked at $2.4M in Q4 2014. 753 funds tracked by Wall St. Rank hold LH as of Q4 2017.

  • PEAK6 Group reported no remaining Labcorp position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 17 Labcorp shares in Q4 2017, an estimated $2.25K.
  • PEAK6 Group first reported a position in Labcorp in Q2 2013 and held it in 11 quarters.
  • PEAK6 Group's Labcorp position peaked at $2.4M in Q4 2014.
  • 753 funds tracked by Wall St. Rank held Labcorp as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.